September 30, 2020

The Niche

Knoepfler lab stem cell blog

false marketing

5 min read

It was fascinating to read a new JAMA piece by the FDA on unproven stem cell clinics and other regenerative medicine firms. Many of these guys are profiteering off of buzz about exciting, but mostly unproven technologies. While the JAMA opinion piece reiterates the agency’s commitment to evidence-based regenerative medicine, it also makes some other key points, some of which are newer and worth digging into on a deeper level. What’s new here from the FDA? The piece by CBER Director Dr. Peter Marks …Read More

2 min read

The Federal Trade Commission (FTC) took some strong action against specific stem cell clinics today and the physician behind them. I see this as really good news and it’s something I’ve been pushing for years. The clinics in question in part marketed unproven stem cells for sick kids. Frankly, iffy for-profit stem cell “treatments” for kids is something that especially pisses me off as it’s even riskier and inherently raises more ethical issues.  In the announcement today, the FTC described a settlement and outlined …Read More

2 min read

One of my Top 20 Predictions for Stem Cells for 2017 was that we’d see more instances of fake stem cell news. One type of stem cell fake news consists of promotional press releases that seek to recruit paying customers for unproven stem cell “treatments” based on made up or exaggerated claims about safety and efficacy or about the stem cell clinic’s credentials. Another kind of fake stem cell news is more ideologically based and is mainly practiced by anti-embryonic stem cell (ESC) websites …Read More